End Stage Renal Disease on Dialysis Clinical Trials

6 recruiting

Frequently Asked Questions

Common questions about End Stage Renal Disease on Dialysis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Comparing Surgical and Endovascular Arteriovenous Fistula Creation

End Stage Renal Disease on Dialysis
University of California, Los Angeles90 enrolled2 locationsNCT05654103
Recruiting

Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access

Chronic Kidney DiseasesEnd Stage Renal Disease on Dialysis
W.L.Gore & Associates72 enrolled5 locationsNCT05846581
Recruiting
Phase 1Phase 2

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Kidney FailureEnd Stage Renal DiseaseKidney Tumor+4 more
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC90 enrolled1 locationNCT07053462
Recruiting
Phase 4

EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease

End Stage Renal Disease on DialysisHeart Failure With Preserved Ejection Fraction
National Taiwan University Hospital150 enrolled2 locationsNCT06249945
Recruiting
Phase 4

Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease

Heart Failure With Reduced Ejection FractionEnd Stage Renal Disease on Dialysis
National Taiwan University Hospital95 enrolled2 locationsNCT06249932
Recruiting

Targeted Deprescribing in Patients on Hemodialysis

End Stage Renal Disease on Dialysis (Diagnosis)
University Health Network, Toronto480 enrolled4 locationsNCT03733262
Recruiting
Not Applicable

HED-Start: Evaluating a Positive Skills Intervention for Patients New on Haemodialysis

End Stage Renal DiseaseEnd Stage Renal Disease on DialysisEnd-stage Kidney Disease+1 more
Nanyang Technological University148 enrolled1 locationNCT04774770